SIR 2019: VERNACULAR trial 12-month results report patency data and clinical benefits of venous stenting

Michael D Dake (Tucson, USA) presented results, at SIR 2019, from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the treatment of iliac and femoral vein occlusions. At one year, the researchers found that the overall patency rate was more than 88%. Importantly, beyond patency data, patients in the trial reported a statistically significant clinical improvement in their pain and quality of life scores over baseline that lasted out to one year.

Dake, Michael

Dr. Michael D. Dake, an internationally recognized physician-scientist, health educator and innovative medical researcher and the senior vice president for health sciences at the University of Arizona.

Add comment

Editor’s Venous Pick

    Subscribeto receive the very best in medical videos